|
|||||
|
|
Inhaled zanamivir versus placebo for the prevention of influenza outbreaks in an unvaccinated long-term care population |
|
| Authors: | Ambrozaitis Arvydas Gravenstein Stefan van Essen Gerrit A Rubinstein Ethan Balciuniene Ligita Stikleryte Ausra Crawford Catriona Elliott Michael Shult Peter |
| Affiliation: | aVilnius University, Vilnius, Lithuania bEastern Virginia Medical School, Norfolk, VA cGlaxoSmithKline Australia Pty Ltd, Melbourne, Australia dGlaxoSmithKline, Research and Development, Greenford, UK eWisconsin State Laboratory of Hygiene, Madison, WI fInfectious Diseases Unit, Chaim Sheba Medical Center, Tel-Hashomer, Israel gJulius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands. |
| Abstract: | |
| Keywords: | Neuraminidase inhibitor zanamivir influenza prophylaxis outbreak control nursing homes long-term care facilities unvaccinated population antiviral resistance frail high risk elderly |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |